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ABSTRACT
Objectives: To explore the views of eye health
professionals and service users on shared community
and hospital care for wet or neovascular age-related
macular degeneration (nAMD).
Method: Using maximum variation sampling, 5 focus
groups and 10 interviews were conducted with 23
service users and 24 eye health professionals from
across the UK (consisting of 8 optometrists, 6
ophthalmologists, 6 commissioners, 2 public health
representatives and 2 clinical eye care advisors to local
Clinical Commissioning Groups). Data were transcribed
verbatim and analysed thematically using constant
comparative techniques derived from grounded theory
methodology.
Results: The needs and preferences of those with
nAMD appear to be at odds with the current service
being provided. There was enthusiasm among health
professionals and service users about the possibility of
shared care for nAMD as it was felt to have the
potential to relieve hospital eye service burden and
represent a more patient-centred option, but there were
a number of perceived barriers to implementation.
Some service users and ophthalmologists voiced
concerns about optometrist competency and the
potential for delays with referrals to secondary care if
stable nAMD became active again. The health
professionals were divided as to whether shared care
was financially more efficient than the current model of
care. Specialist training for optometrists, under the
supervision of ophthalmologists, was deemed to be
the most effective method of training and was
perceived to have the potential to improve the
communication and trust that shared care would
require.
Conclusions: While shared care is perceived to
represent a promising model of nAMD care, voiced
concerns suggest that there would need to be
greater collaboration between ophthalmology and
optometry, in terms of interprofessional trust and
communication.
Trial registration number: ISRCTN07479761.
INTRODUCTION
Age-related macular degeneration (AMD) is
one of the leading causes of severe visual loss
in the world,1 accounting for over half of
blind and partial sight certiﬁcations in the
UK.2 In 2010, it was estimated that 608 213
people in the UK had AMD, with an
expected increase to 755 867 by the end of the
decade.1 This will continue to place an enor-
mous strain on healthcare services in the UK,
where the cost of sight impairment was esti-
mated to be £22 billion in 2008.3 In addition,
the vision loss associated with AMD has been
shown to severely impact on a patient’s quality
of life, being associated with loss of independ-
ence, depression and social isolation.4
Since 2008, the National Institute for
Health and Care Excellence (NICE)
Strengths and limitations of this study
▪ This is the first study to explore perspectives of
shared care for neovascular age-related macular
degeneration, and provides important insights
into possible barriers and facilitators to imple-
mentation that would need to be incorporated
into the planning of any pilot scheme.
▪ A purposeful sampling approach was adopted to
ensure that the feasibility and acceptability of the
proposed shared model of care was captured
from a range of perspectives, and the constant
comparative method provided an opportunity to
highlight similarities and differences between the
participants.
▪ Optometrists and ophthalmologists were attend-
ing specialist conferences and therefore, may
represent a more motivated and enthusiastic
group of professionals. Similarly, service users
were recruited from Macular Society support
meetings; so they may represent a more pro-
active and informed group of patients.
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recommended that the National Health Service (NHS)
hospital eye service (HES) should use the antivascular
endothelial growth factor drug ranibizumab in England
and Wales to treat patients with neovascular age-related
macular degeneration (nAMD) until the neovascular
process becomes quiescent or ‘stable’ for at least
3 months. The disease can reactivate at any time so
patients with quiescent disease are required to be moni-
tored by monthly visits to assess the need for retreat-
ment.5 This has created a substantial increase in HES
workload, with clinics struggling to provide regular
monthly reviews.6 Timely retreatment has been shown to
be critical in maintaining visual acuity and preventing
vision loss. Since delays in follow-up beyond the recom-
mended monthly interval can result in vision loss that
may be irreversible and consequently impose additional
burdens on health and social care, a number of potential
solutions to relieve the HES burden have been outlined.6
One possible strategy to minimise the load on second-
ary care is the use of community optometrists for moni-
toring ‘stable’ patients (patients deemed to be at low risk
of requiring retreatment). The ‘Effectiveness of
Community versus Hospital Eye Service’ (ECHoES) trial
was a web-based trial (ISRCTN: 07479761) designed to
assess whether community-based optometrists can
monitor patients with nAMD that has been rendered qui-
escent, using colour and optical coherence tomography
(OCT) images and clinical examination, and accurately
identify who needs to be referred back to an ophthal-
mologist for retreatment if the disease becomes active
again. This would be a pre-requisite for establishing a
shared care scheme whereby the greater part of the mon-
itoring of patients with stable nAMD disease could be
undertaken in a community setting. This change in
service provision would free up clinic capacity in the HES
and allow clinicians to concentrate on monitoring and
treating patients during the ‘active’ phase of nAMD.
However, even if community optometrists can be
shown to have levels of diagnostic accuracy and manage-
ment competence equivalent to ophthalmologists, there
are many other reasons why a change in service provi-
sion may be challenging. These include staff training
and competency assessment, costs and patient accept-
ance.6 It is, therefore, important to ascertain the per-
spectives of health professionals and service users.7
Various studies have explored the acceptability and feasi-
bility of enhancing optometric services to relieve the
HES burden for a range of eye diseases;8–12 however,
none have done so speciﬁcally for monitoring nAMD.
Therefore, the purpose of the current study was to
explore health professionals’ and service users’ perspec-
tives of shared care for nAMD through focus groups and
interviews, as part of the ECHoES trial.
METHOD
Recruitment and sampling
Optometrists and ophthalmologists were recruited from
those due to attend annual UK-based specialist
conferences—the National Optical Conference and the
Royal College of Ophthalmologists annual congress.
Those who expressed an interest after hearing about the
study were emailed further information along with a par-
ticipant information leaﬂet. Leads of Clinical
Commissioning Groups (CCGs) in England were
emailed study information and asked to forward it to the
general practitioners (GPs)/Commissioners in each
CCG who were involved in commissioning eye health-
care. In each case, those who were initially interested
were asked to contact the researcher for more informa-
tion. Additional clinical advisors and public health
representatives were identiﬁed by the snowball tech-
nique, in which healthcare professionals provided the
names of other potentially interested colleagues.
Service users with nAMD were recruited from local
support groups organised by the Macular Society (a
UK-based charity for anyone affected by central vision
loss). Service users with any history of nAMD were invited
to join the study (regardless of whether they had nAMD
in one eye or both, dry AMD in their other eye, or were
currently receiving or had any treatment in the past).
Three support groups in South West England were pur-
posefully selected–one based in a major city, a large town
and a rural village. DT attended local support meetings to
explain about the research and provide attendees with a
participant information leaﬂet. Contact details of those
potentially interested were obtained and they were tele-
phoned a week later to discuss the study further.
A purposeful sampling strategy was used to ensure
that the feasibility and acceptability of the proposed
shared model of care for nAMD was captured from a
range of perspectives. Within this sampling approach,
maximum variation was sought in relation to profession,
age, gender and geographic location (for health profes-
sionals), and gender, age, type of nAMD and time since
diagnosis (for service users). Participant characteristics
were assessed as the study progressed, and individuals or
groups that were under-represented were targeted (ie,
commissioners or clinical advisors). Where it was felt
that variation had been achieved, potential participants
were thanked for their interest and informed that sufﬁ-
cient numbers had been recruited (ie, optometrists).
Data collection
Focus groups were conducted separately for optometrists
and ophthalmologists at the specialist conferences.
Focus groups with service users were held alongside the
Macular Support local meetings in a separate room.
Individual interviews were conducted with healthcare
commissioners, clinical advisors to CCGs and public
health representatives at a convenient location or over
the telephone if preferred. Discussions were led by the
participants themselves, with DT ﬂexibly guiding focus
groups and interviews by occasionally probing for more
information, clarifying any ambiguous statements,
encouraging the discussion to stay on track, and
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providing an opportunity for all participants in the focus
groups to contribute to the discussion.
Separate topic guides were developed for service users,
optometrists/ophthalmologists (with additional ques-
tions for each professional group), and all other health
professionals to ensure that discussions within each
group covered the same basic issues, but with sufﬁcient
ﬂexibility to allow new issues of importance for the infor-
mants to emerge. These were based on the study aims,
relevant literature and feedback from eye health profes-
sionals in the ECHoES study team, and consisted of open-
ended questions about the current model of care for
nAMD and perspectives of stable patients being moni-
tored in the community by optometrists (see online sup-
plementary appendix). These were adapted as the
analysis progressed to enable exploration of emerging
themes. Written consent was obtained from each partici-
pant at the start of the focus group or interview. A digital
voice recorder was used to record the discussions. All par-
ticipants were offered a £20 gift voucher to thank them
for their time. The focus groups and interviews were con-
ducted between November 2013 and June 2014.
Data analysis
Audiorecordings were transcribed verbatim and checked
against the audiorecording for accuracy. Transcripts were
imported into NVivo (V.10), where data were systematic-
ally assigned codes and analysed using constant compari-
son methods derived from grounded theory
methodology.13 Emerging themes were discussed with a
second experienced social scientist (NM), with refer-
ence to the raw data. Data collection and analysis pro-
ceeded in parallel, with emerging ﬁndings informing
further sampling and data collection. Analysis continued
until the point of data saturation, that is, the point at
which no new themes emerged.
RESULTS
Participants
Health professionals
One focus group was undertaken with optometrists and
another with ophthalmologists, lasting a mean of
91 min. Ten interviews were conducted with other
health professionals (6 face-to-face and 4 over the tele-
phone) with a mean duration of 48 min. In total, 24
health professionals were recruited (8 optometrists, 6
ophthalmologists, 2 public health representatives, 6 NHS
commissioners and 2 clinical eye care advisors to their
local CCGs). Of these, 12 were women and 12 men.
These participants had a mean age of 39 years (range
31–64 years) and had been in their profession for a
mean of 21 years (range 4–40 years). Although none
had participated in any form of shared care for nAMD,
11 had experience of shared care schemes for other
conditions (eg, diabetic retinopathy screening and
ocular hypertension monitoring). Table 1 provides back-
ground information on the health professional
participants. Years in profession and location are not
given for the ‘other’ health professionals (ie, those
other than ophthalmologists and optometrists) to
protect their anonymity given their unique roles.
However, these other professional participants were dis-
tributed geographically throughout England and they
had been in their profession for an average of 20 years
(range 8–37 years).
Service users
Three focus groups were conducted with 23 service users
(with 7 or 8 in each group) and lasted a mean of 71 min.
The sample consisted of 15 women (65%) and 8 men
(35%) who described themselves as white British. The
sampling strategy intended to recruit individuals from a
mix of ethnicities, but all those at the supporting groups
who were willing to be contacted were white British. They
had a mean age of 82 years (range 72–93 years). All had
nAMD, attended the same eye hospital in a major city
and had been diagnosed, on average, 5.9 years ago
(range 6 months to 20 years). Nine participants had
active nAMD in one eye (39%), nine had quiescent
nAMD in one eye (39%), four people had active nAMD
in both eyes (18%) and one person had quiescent nAMD
in both eyes (4%). Eight participants had dry AMD in
their other eye (35%). Table 2 provides service user parti-
cipants’ demographic and health-related details.
Analysis
Six main themes emerged from the data, as detailed
below.
Current clinic capacity: pushed to the limit
Many health professionals stated that the number of
repeat hospital visits for patients was rising exponentially,
which they attributed to an increase in the number of
patients who were being diagnosed with nAMD and new
government guidelines for treatment. Hospital clinics
were felt to be ‘pushed to their limit’ (Optom7,
Ophthalm3) and the ophthalmologists felt frustrated
that their time was mostly spent on stable patients who
did not require treatment.
You are taking the potential time from the ones that actu-
ally need the care. There is a limit of work that you can
do. I mean you can’t go home at 8 every day.
(Ophthalm2)
Both the health professionals and service users
described how patients would often have to wait for long
periods of time for their appointment because of how
busy the eye hospital clinics were.
Well, quite honestly when you go to the eye hospital, it
always seems to be packed out left, right and centre.
(Harry)
Sometimes we have to wait a long time, but you know it
can’t be helped. (Henry)
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It’s just generally the issue of they have had to wait a long
time […] You’ve got to think also there are diabetics
among there that have to regulate their meals, and they
have their set routine in terms of their meals and health.
It’s the same with everybody, but perhaps diabetics most,
because it affects them straight away. I’ve known diabetics
that have gone into a hypo [hypoglycaemia] because
they were waiting around. Because they had a nine
o’clock appointment and it got to eleven. It’s just a real
shame. (PH2)
There was a sense that the current model of care for
nAMD would inevitably need to adapt to cope with this
demand and consensus that monitoring in the commu-
nity could reduce the clinical workload.
It will help shift a lot of the workload out of the hospital
environment where they are overrun with this and
putting it into a more capable environment with local
optometrists. (Optom6)
[Monitoring in the community] will make less queues at
the hospital. At the moment they’re choc à bloc with
people. (Ruth)
The optometrists, clinical advisors and commissioners
also described how a shared care scheme represented an
opportunity to enhance optometrists’ professional roles
by developing their skills.
It’s fantastic for the optometry profession, because it
must give them much more exciting and interesting
careers, and career progression, and variety within their
work. (Comm3)
Potential for a more patient-centred model
Most health professionals believed that the current
model of care was not appropriate for older patients
with limited vision who had to regularly travel to the hos-
pital. In line with this, the service users found it stressful
travelling to and from the hospital for care. Those who
used public transport had difﬁculty seeing bus numbers
and often needed to get multiple buses. Others were
driven by family or friends, but described the availability
of parking as ‘awful’ (Arthur).
It’s not just getting to the hospital. It’s all that time after-
wards, if you’ve got to get the bus, it’s—in the winter, it’s
even worse. (Ralph)
Table 1 Health professional participants’ background
Participant* Role(s)
Years in
profession† Location†
Focus group 1
Optom1 Optometrist 37 South West England
Optom2 Optometrist 28 South East England
Optom3 Optometrist 29 North West England
Optom4 Optometrist 37 West Midlands
Optom5 Optometrist 15 South West England
Optom6 Optometrist 20 South West England
Optom7 Optometrist 36 South West England
Optom8 Optometrist 40 West Midlands
Focus group 2
Ophthalm1 Ophthalmologist 20 North West England
Ophthalm2 Ophthalmologist 20 London
Ophthalm3 Ophthalmologist 4 Dundee
Ophthalm4 Ophthalmologist 7 East Midlands
Ophthalm5 Ophthalmologist 17 North West England
Ophthalm6 Ophthalmologist 3 South West England
Interviews
CA1 Optometrist, clinical advisor to local CCG – –
CA2 Optometrist, clinical advisor to local CCG – –
Comm1 Commissioner, pharmacist – –
Comm2 Commissioner, GP – –
Comm3 Commissioner, GP – –
Comm4 Commissioner, GP – –
Comm5 Commissioner, pharmacist – –
Comm6 Commissioner, optometrist – –
PH1 Member of Eye Health Local Professional Network, optometrist – –
PH2 Optical advisor for eye charity, optometrist – –
*Health professionals are identified by their professional role and their individual participant number.
†Owing to their unique role, the other health professionals’ years in profession and location have been removed to protect anonymity.
CA, clinical advisor; Comm, Commissioner; CCG, Clinical Commissioning Group; GP, general practitioner; Ophthalm, ophthalmologist;
Optom, optometrist; PH, public health representative.
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One of the things that’s come out here is that everyone
is, obviously, getting older. They’re stressed when they
have to go out of the town because getting home when
you’ve got … (Robert)
Oh, it’s terrible. (Mandy)
So if they have someone in the town who is an optician
and deals with us, it’s only a short distance from home.
(Robert)
[Focus group extract]
The problem is that all the patients have got to go to the
eye hospital all the time, which isn’t very patient-
centric… It’s not very easy for people to get in once a
month—which is obviously what Lucentis is about—for
their assessment. Given that they are, almost by deﬁn-
ition, elderly and with poor vision, it’s not an ideal
centre for it. (Comm2)
Monitoring in the community was described as a ‘won-
derful’ idea (Elizabeth), particularly for those who lived
further away from the hospital or older participants who
had severe vision loss.
For me, living out of town in [small town], to get to an
optician on the bus is easy, whereas it’s a day’s expedition
to come into [city]. (Tracey)
Many rarely saw the same consultant or nurse at the
hospital, and felt that staff were often impersonal as they
were so busy. This was likened to ‘being on a conveyer
belt’ (Pam).
If a doctor said, “Well, that’s alright”, that’s it. It’s reassur-
ance. I think they’re trying to speed up time, and I know
they’re very busy and they obviously look at the photo-
graphs and they can see everything, but for patients’ feel-
good interest, I always like a doctor…just to talk to you
properly. (George)
The only criticism I would have is to try to ﬁnd out how
you’re doing and whether you’re getting worse or getting
better, or stable, because they’re all so busy. (Ruth)
These participants were, therefore, enthusiastic about
the potential for continuity of care where they hoped to
build up a relationship with their optometrist.
Many aspects of the eye hospital, it’s so impersonal. I
think that probably a system like you’re suggesting would
probably add a personal touch to it and a more one on
one situation…That’s the big thing, seeing the same
person. Like I said, the personal touch…The relationship
would build up. (Edward)
Table 2 Service user participants’ demographic and health-related details
Participant* Gender Age
Location of
support group Information about condition
Time since
diagnosis (years)
Focus group 3
Arthur Male 80 City Advanced active nAMD in one eye 20
Edith Female 83 City Inactive nAMD in one eye 7
Edward Male 78 City Active wet in one eye, dry in other 10
Elizabeth Female 81 City Inactive wet in one eye, dry in other 12
Harriett Female 86 City Inactive nAMD in one eye, dry in other 2.5
Kath Female 77 City Inactive in nAMD in both eyes 15
Ruth Female 87 City Active nAMD in one eye 10
Tom Male 79 City Inactive wet in one eye, dry in other 13
Focus group 4
Alice Female 79 Large town Inactive nAMD in one eye 5
Debbie Female 84 Large town Advanced active nAMD in one eye, dry in other 4
Julie Female 86 Large town Active nAMD in one eye, dry in other 6
Mandy Male 93 Large town Active nAMD in one eye 6
Maria Female 93 Large town Inactive nAMD in one eye 20
Pam Female 83 Large town Active nAMD in one eye, dry in other 4
Ralph Male 79 Large town Active nAMD in one eye 7
Robert Female 78 Large town Active nAMD in both eyes 10
Focus group 5
George Male 85 Rural village Active nAMD in both eyes 6
Harry Male 72 Rural village Inactive nAMD in one eye 1
Henry Male 82 Rural village Active nAMD in one eye, dry in other 4
Olivia Female 84 Rural village Active nAMD in both eyes 8
Pat Female 78 Rural village Active nAMD in both eyes 7
Tracey Female 77 Rural village Inactive nAMD in one eye 11
Yvonne Female 76 Rural village Inactive nAMD in one eye 1
*Pseudonyms were assigned to participants.
nAMD, neovascular age-related macular degeneration.
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Perceptions of optometrists’ competency
The optometrists in the focus groups, who acknowl-
edged that they had a special interest in nAMD, were
very positive about the possibility of shared care and felt
that their profession was more than capable of monitor-
ing in the community. This was echoed by the commis-
sioners, clinical advisors and public health
representatives.
They’re [optometrists] really incredible, impressive pro-
fessionals, with just a huge amount of experience at
looking at eyes. (Comm3)
However, several health professionals (from mixed
professions) commented that ophthalmologists would
resist shared care as they were not convinced of optome-
trists’ competence.
I think it’s the misconception that optometrists won’t do
as good a job as secondary care. So I think that’ll be the
biggest barrier. (Comm4)
This was considered to be problematic for shared care
as there was uncertainty as to whether ophthalmologists
would ever truly relinquish responsibility of patients.
Honestly, I think that clinicians aren’t always very good at
letting go […] It will be an issue. (Comm3)
I would not want to close the door on them [stable
patients], ever. (Ophthalm1)
There was hesitation by ophthalmologists as to
whether optometrists were capable of monitoring
nAMD. The ophthalmologists referred to how they fre-
quently received incorrect referrals from optometrists.
Furthermore, they highlighted the ways in which nAMD
differed to other eye diseases where shared care
schemes existed.
When you work in ophthalmology for quite some time
you see just the amount of work that comes to you from
inappropriate referrals. Really they’re just doubling work
up. (Ophthalm3)
This is not like glaucoma where you notice pressure or
you don’t feel okay and refer back to the hospital. This is
something…it’s based on the scan and each patient is dif-
ferent. There’s only a few parameters for glaucoma,
whereas here there are…it’s complex […] So we can’t
expect an optometrist to…[laughter]. (Ophthalm5)
The ophthalmologists felt that the hospital provided
an environment where they had access to all previous
scans and other colleagues’ expertise, which enabled
them to conﬁdently make a clinical judgement. They
expressed uncertainty about whether optometrists would
have these resources. Ultimately, due to this perceived
complexity of assessing the need for retreatment, and
the support and resources available in the hospital, the
ophthalmologists felt that monitoring patients in the
community would be a compromise.
So what we are trying to say is hospital care is the best
[laughter]. (Ophthalm6)
Several ophthalmologists felt that patients would
prefer to remain being monitored by a consultant at the
hospital, whom they would inherently trust. In line with
this, service users with active nAMD also tended to be
apprehensive about the level of optometrist competence
in the community and commented that lengthy waiting
times were secondary to receiving the best care for their
condition.
If we put ourselves in their position what would we prefer
to have? I’ll prefer to be seen by a doctor in a hospital.
(Ophthalm1)
So, you’ve got to have conﬁdence in the person that is
monitoring you […] I feel that to rely on somebody that
has been trained up to identify problems can’t really be
as efﬁcient as seeing an actual doctor who specialises in
that subject, and because of that, I wouldn’t be happy
going to an optician. It might take you longer. We have
sat up there for hours, but the end result is well worth it.
(Henry)
The majority of service users described needing to be
able to have faith in their optometrist if they were to par-
ticipate in shared care. Those whose optometrist had
diagnosed their nAMD commented that this gave them
a sense of conﬁdence in their optometrist’s abilities.
I would trust my optician. He really seems to care.
I would trust him. If my wet macular was stable, I’d be
very happy to go to my optician because I’ve got conﬁ-
dence in him, because he detected it in the beginning.
(Harriett)
However, a few service users were apprehensive about
shared care and did not wholly trust the idea of monitor-
ing by an optometrist. Those that expressed this did not
have faith in their optometrist because the optometrist
had not recognised the condition initially.
Personally I wouldn’t have faith in the optometrist.
I would much prefer to stay with the hospital. (Henry)
(Lack of ) Communication between optometrists and
ophthalmologists
Overall, the health professionals described the relation-
ship between optometry and ophthalmology as poor.
Collaboration optometry and ophthalmology? No way. It’s
absolutely dreadful! [laughter] (Optom8)
These participants described how system-based issues
accounted for the poor communication between the two
professions. This was described by all professions except
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the ophthalmologists. For instance, most optometrists
described how it could be extremely difﬁcult to relay
information to ophthalmologists because of incompat-
ible email systems and variation in technology.
Our problem is we’ve got NHS.net in optometry and
because everyone else, they’re all NHS.co.uk. So their end
isn’t secure. We can do NHS.net to NHS.net, but we can’t
do NHS.net to NHS.co.uk, which is what all hospitals give
their consultants. It’s absolutely crazy. (Optom8)i
They’ve not embraced NHS.net at all. (Optom5)
Some optometric practices don’t even have computers.
Particularly in the [city] area where many of them are
way behind. We actually had to buy them fax machines
when this started to make it work. You’d expect most
people had that sort of facility, but they didn’t. To make
it work, we would do that. So I think standardisation of
forms across our units, across the country, and making
those forms readily available, and everybody knows that
they’ve got to look for the red-topped form in the prac-
tice or whatever, could possibly aid this model of shared
care. (Optom2)
The other big issue is transfer. If you’re actually going to
transfer the data, they are massive, massive, massive ﬁles.
I was talking to an optometrist who has an OCT and
sends scans to an ophthalmologist, and he literally has to
do it overnight. Just for one patient, it takes so long.
(Optom1)
[Focus group extract]
All of the optometrists also commented that this had
caused issues with their referrals to ophthalmologists in
the past, in that they often got lost between the two pro-
fessions. As a result, the optometrists stated that they
would try to follow-up each referral by calling the con-
sultant to ensure it had been received or they sent refer-
rals via multiple technology methods to ensure that one
would reach the consultant.
It does happen that patients will wander back in two
weeks later and say, “Oh, you told me I’d be seen within
a couple of weeks. I haven’t heard a thing”. Then we
contact the hospital and we think, “Okay, what’s happen-
ing?” (Optom2)
Many participants (health professionals and service
users) explained that one of the key concerns of nAMD
was the rapid progression of the disease if the condition
became active. In particular, several service users
described the devastating consequences of their vision
deteriorating within days.
Last week I was all-seeing and driving and everything,
and on Thursday I thought, “There’s something missing
on that signpost”, and the glare was terrible. So then I
couldn’t read the paper at lunchtime…To me, it’s been a
disastrous week. I can no longer drive. I can no longer
read. This is a week! To me, that’s a disaster. It’s very
frightening. (Pat)
Therefore, the participants, particularly the ophthal-
mologists and service users, expressed concerns about a
potential delay between primary and secondary care
sectors if retreatment was required.
The problem is that the more steps you have in the system,
the longer it takes. We don’t have the time. (Edward)
If you are in the community and it’s not stable, then you
have to have a very quick way of getting back to treat-
ment. So those are my concerns. (PH1)
The health professionals emphasised the importance
of the two professions working collaboratively so that an
efﬁcient pathway could be developed.
You’d need to be sure that there’s a seamless process
between community and hospital, and that nothing
drops through the cracks. So I think they would need to
make sure that there’s a robust recall service, and that if
there is an issue, that there’s a pathway back for the
patient into secondary care. (Comm2)
The cost of shared care
Although the optometrists and the ophthalmologists
believed that ﬁnancial considerations should be second-
ary to patient outcomes, the other health professionals
stated that a harsh reality of healthcare was that shared
care would not be commissioned unless it ‘got the most
out of the NHS pound’ (PH2).
You’ve got to show the CCGs that you’re saving money
over sending them into the hospital. Because otherwise,
they’re just not going to commission it. (PH1)
The commissioner participants undertook several
roles professionally and were often optometrists or GPs
alongside this position. The multiple perspectives from a
commissioning and clinical point of view appeared to be
in conﬂict when contemplating nAMD care, in terms of
patient outcomes and ﬁnancial efﬁciency.
Patients would like it [being monitored in the commu-
nity] because it’s much closer to home, they don’t have
to go to hospital. They don’t have to sit and queue and
wait in pain, park and all that sort of stuff that patients
usually tell you…[…] From a commissioner’s perspec-
tive… In terms of saving and shifting costs across the
health system for eye care services, it certainly doesn’t
achieve that. (Comm4)
Among the health professionals, there was disagree-
ment as to whether shared care would represent a
iNHS.net and NHS.co.uk are email systems for NHS employees in
England and Scotland.
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cost-efﬁcient model. For instance, many perceived that
differential fees for optometrists and ophthalmologists,
as well as decreased costs of managing sight loss, may be
ﬁnancial incentives to commission shared care.
It would be a cost efﬁcient option for the commissioners
because we would be paying something like £60 for an
optometrist to measure the patient’s visual acuity, rather
than £100 and whatever it is for a consultant outpatient
episode. (Comm4)
You could use the monitoring to stop the wet AMD
getting worse, so that it’s kind of preventative, then you
would be addressing the public health indicator of drop-
ping those numbers of people registered with AMD sight
loss. (PH2)
However, there was agreement that the equipment to
obtain OCT images, although considered essential for
monitoring nAMD, was an expensive piece of kit that
not all practices might be able to invest in. The clinical
advisors and public health representatives felt that CCGs
should provide OCTs, although most of the commis-
sioners and the ophthalmologists felt it should be
self-funded to demonstrate a level of commitment to
monitoring in the community.
Well, it’s on the optometrists, really. Whether they’ve got
the kit or whether they will want to invest in one. I think
what it will be is that you’d have a small group of prac-
tices within a particular area, who will show keenness.
[…] They will be the more cutting edge practices.
(Comm6)
I think CCGs should pay for that [an OCT], the NHS.
I don’t think it should be the optometrist. (PH2)
While the ophthalmologists stated that they took
around 15 min to see a patient and determine the need
for retreatment, the optometrists’ estimates varied
between 20 and 40 min, with the latter estimate of up to
40 min being more realistic to make a clinical decision
and explain the results to the patient.
I’ll allow 30 and probably spend 40 […] But once you’ve
got an OCT sitting there and you start looking at it, and
you really want to explain it to the patient and they say,
“Oh, thank you. No one ever tells me anything like that
at the hospital. It makes you feel so good at the end.
You’ve actually told the patient what’s really wrong and,
“Rest assured my dear, it’s not getting any worse, so we
don’t need to send you back. ‘‘Oh, thank you!” It prob-
ably would take me 40 minutes. (Optom8)
Several commissioners and one clinical advisor also
highlighted a potential conﬂict between practices’ clin-
ical and commercial interests, and stated that optome-
trists would need to be paid a sufﬁcient amount to
ensure that shared care was ﬁnancially possible.
They [optometrists] make the majority of their money on
spectacles, and things like that. They get paid a minimal
amount for seeing patients… They need to be paid at a
certain level, which allows them to invest in the equip-
ment, and IT systems for regular follow up, all that kind
of stuff. (Comm2)
There were also concerns that CCGs might be
charged for repeat tests if ophthalmologists lacked trust
in optometrists’ judgements.
We would want to make sure we would only be being
charged for that element of it, and they [ophthalmologists]
wouldn’t go on and repeat all the tests again. (Comm1)
The importance of specialist training
The health professionals spent a considerable amount
of time discussing how they felt training should be deliv-
ered, in terms of which method was most effective for
learning, and ensuring the training was delivered in a
way that would reassure ophthalmologists that optome-
trists were being trained to a high standard.
“I think the training needs to be very carefully designed”.
(PH2)
“The ophthalmologists have to believe in the competence
of the optometrist. It’s important that they have belief in
the quality of the accreditation”. (Optom4)
Virtual training was deemed appropriate for providing
a foundation level of knowledge, although most felt that
this alone would not be sufﬁcient to train the optome-
trists. In particular, the ophthalmologists were uncon-
vinced by the applicability of a virtual trial.
I’m sure in your studies you will ﬁnd 100% virtual case
studies that you give, that you will ﬁnd good correlation
between what the ophthalmologist would say and what
the optician would say in a virtual case. You can’t just say
“Yes, the optom has 100% exactly the same as the oph-
thalmologist, which says that now they are just as good.”
(Ophthalm3)
Clinical experience—whereby optometrists would gain
experience of monitoring nAMD patients in a hospital
setting—was viewed as an essential component of
training.
I would suggest that they [optometrists] would spend a
certain amount of time in a consultant clinic… That will
help the consultants gain a bit of conﬁdence in the
optom as well. So it’s a working partnership going on
there. (Comm2)
I think they need to come and see the real patient.
There’s no point on sitting on the MediSoft or whatever
and clicking boxes and thinking they know it all. Real life
is not like that. I mean there are the OCT scans like that,
sometimes they can be very devious and very challenging
and very confusing… (Ophthalm2)
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The majority of participants felt that having ophthal-
mologists’ supervising this clinical training would
provide assurance about the optometrists’ competence
and enable greater collaboration between the two pro-
fessions. However, they acknowledged that this would be
time-consuming.
I think they would be involved if they had an element of
control over it. If they’d done the training and if they
knew who they were sending the patients out to and they
knew what protocols were being followed, the service
spec. You don’t get these things to work unless you’ve got
clinical buy in. You just don’t. You can set up all you
want, but you’ve got to get the clinicians involved.
(Optom5)
Obviously it has to be somebody senior who has responsi-
bility of training them and signing them off.
(Ophthalm1)
Is that something that you would be willing to do, to
train an optometrist? (DT)
Where’s the time? (Ophthalm1)
Exactly. (Ophthalm4)
We’d have to stop doing the MD clinics and start train-
ing. (Ophthalm2)
[Focus group extract]
DISCUSSION
This study has provided important insights into health
professionals’ and service users’ perspectives of shared
care for patients with nAMD. Overall, the ﬁndings
suggest that the needs and preferences of those with
nAMD appear to be at odds with the current service
being provided. There was enthusiasm from health pro-
fessionals and service users for a shared model of care as
it was felt to have the potential to relieve HES burden
and represent a more patient-centred option. However,
there was uncertainty as to how this could operate in
real life, including uncertainty about start-up costs and
payment scales, about demand and patient ﬂows, and
about how hospital-community communications would
work in practice. This suggests the need for pilot studies
to work out the practicalities and provide real-life proof
of concept.
There appeared to be unmet needs for those with
nAMD that could be better met by delivery of a shared
hospital and community care scheme. In line with previ-
ous research, the service users described frustration at
the lack of support and information they received at hos-
pital14 15 and felt that being monitored in the commu-
nity would enable them to build up a relationship with
an optometrist. Furthermore, a shared care scheme was
attractive due to the convenience of being monitored
closer to their homes, as found in other studies.7 12 With
the burden of hospital follow-up visits for patients with
stable nAMD,6 the health professionals felt that shared
care could also relieve the ophthalmology workload.
However, a number of possible barriers to implement-
ing a shared care scheme were identiﬁed. Several
ophthalmologists and service users voiced concerns
about the optometrist’s competence and a potential
delay in retreatment should the need arise. Previous
research has found that patients decline other shared
care schemes because of the reputation of and familiar-
ity with hospital services,12 and specialists are not con-
vinced of optometrists’ expertise, even with additional
training.16 O’Connor et al12 conducted interviews with
optometrists, ophthalmologists and patients who had
participated in a shared care scheme for dry AMD, dia-
betic retinopathy and glaucoma. They concluded that
without time invested in relationship building, ophthal-
mologists’ reservations about the capabilities of optome-
trists could be a barrier to implementing shared care. In
the current study, the health professionals felt training
for optometrists, under the supervision of ophthalmolo-
gists, would improve the communication and trust
between the two professions that shared care would
require.
The health professionals considered the ﬁnancial
implications of moving to a shared care model. There
was agreement that optometry practices may struggle to
obtain appropriate equipment, but uncertainty as to
how funding for OCTs would be provided. Studies
exploring optometrists’ perspectives of extending or
enhancing their roles have highlighted a conﬂict
between the retail and clinical side of the optometric
practice.10 11 16 Although it is important to note that the
points raised are an interpretation of the cost of shared
care, rather than an objective measure, there was uncer-
tainty as to whether shared care was ﬁnancially more efﬁ-
cient than the current model of care. However, Amoaku
et al6 state that adapting nAMD care may be a necessary
investment to improve patient care, increase productivity
by maximising the use of experienced clinicians, and
ultimately reduce the health and social costs of sight loss
in the long term.
Strengths and limitations
The main strength of this research is the use of qualita-
tive methodology to provide important insights into the
under-researched area of whether shared care for
nAMD can and should be implemented by assessing its
acceptability to service users and healthcare profes-
sionals.17 Focus groups provided an opportunity for par-
ticipants to prompt each other about a range of issues
relating to shared care which may not have been consid-
ered individually. Interviews provided a rich account of
the perceived feasibility and acceptability of shared care
scheme as the ﬁndings from the focus groups could be
followed up further and explored in-depth.
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Participating optometrists and ophthalmologists were
attending specialist conferences; so they may represent a
more motivated and enthusiastic group of professionals.
Similarly, service users were recruited from Macular
Society support meetings; so they may represent a more
proactive and informed group of patients.15 However, a
purposeful sampling approach was adopted to ensure
that we captured a range of perspectives from different
participants within these constraints. Furthermore, posi-
tive and negative views were provided, suggesting partici-
pants carefully considered the practicalities of
implementing shared care. Although service users
attended the same eye hospital for their nAMD care, the
themes relating to current experiences of hospital care
have also been highlighted in previous research.7 12 15
None of the participants had the experience of shared
care for nAMD. It has been questioned whether evalua-
tions of hypothetical scenarios accurately relate to judge-
ments in real-life situations.18 However, the issues
identiﬁed in this study mirror many of the ﬁndings from
other studies in which participants had experience of
shared care for other eye conditions. Our ﬁndings high-
lighted similar potential barriers which could limit the
feasibility of a shared care scheme, including percep-
tions of optometrists’ competence, poor interprofes-
sional communication, and the cost of implementing
shared care.11 12
CONCLUSION
This study demonstrates that there is enthusiasm for
shared care for monitoring nAMD as this could better
meet the needs of those with the condition than the
current model of care. However, ophthalmologists and
service users would need reassurance that greater con-
venience would not be substituted by a lower standard of
eye care, both in terms of optometrist competence and
the speed of the referral pathways back into secondary
care if retreatment was deemed to be necessary. There
also seemed to be poor communication and trust
between ophthalmologists and optometrists; most profes-
sions agreed that, if shared care were to be implemen-
ted, it would need to be done in a way that ensures the
two professions were working more collaboratively.
These ﬁndings would need to be incorporated into the
planning of any pilot scheme for shared care of nAMD.
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